Search Results - "Oyetayo, Ola O"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Dronedarone: A New Antiarrhythmic Agent by Oyetayo, Ola O., Rogers, Carrie E., Hofmann, Prudence O.

    Published in Pharmacotherapy (01-09-2010)
    “…Dronedarone is an antiarrhythmic agent recently approved by the United States Food and Drug Administration for the reduction of cardiovascular‐related…”
    Get full text
    Journal Article
  2. 2

    The Hispanic Diabetes Management Program: Impact of community pharmacists on clinical outcomes by Oyetayo, Ola O., PharmD, MSc, BCPS, James, Clyde, BSPharm, Martinez, Anita, BSPharm, CDE, Roberson, Kim, BSPharm, Talbert, Robert L., PharmD, BCPS, FAHA, FCCP

    “…Abstract Objective To assess the impact of community pharmacists on clinical outcomes in Hispanic patients with type 2 diabetes. Methods 126 patients were…”
    Get full text
    Journal Article
  3. 3

    An Unusual Case of Flecainide‐induced QT Prolongation Leading to Cardiac Arrest by Oguayo, Kevin N., Oyetayo, Ola O., Costa, Steven M., Mixon, Timothy A.

    Published in Pharmacotherapy (01-05-2014)
    “…Flecainide is recommended as a first‐line antiarrhythmic drug to maintain normal sinus rhythm in patients with atrial fibrillation (AF) who have structurally…”
    Get full text
    Journal Article
  4. 4

    Successful Use of Therapeutic Hypothermia in a Pregnant Patient by Oguayo, Kevin N, Oyetayo, Ola O, Stewart, David, Costa, Steven M, Jones, Richard O

    Published in Texas Heart Institute journal (01-08-2015)
    “…Out-of-hospital cardiac arrest is a leading cause of death in the United States. Pregnant women are not immune to cardiac arrest, and the treatment of such…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Proton pump inhibitors and clopidogrel: is it a significant drug interaction? by Oyetayo, Ola O, Talbert, Robert L

    Published in Expert opinion on drug safety (01-07-2010)
    “…Clopidogrel is indicated as part of a dual antiplatelet therapy (DAT) with aspirin for the prevention of cardiac related events in acute coronary syndromes…”
    Get more information
    Journal Article
  7. 7
  8. 8